Benralizumab's anti-eosinophil efficacy may be decreased by impaired NK cell activity.

Poznanski, Sophie M; Portillo, Ana; Mukherjee, Manali; Bhalla, Anurag; Son, Kiho; Ashkar, Ali A; Khalidi, Nader; Nair, Parameswaran

Poznanski, Sophie M; Portillo, Ana; Mukherjee, Manali; Bhalla, Anurag; Son, Kiho; Ashkar, Ali A; Khalidi, Nader; Nair, Parameswaran.

Afiliación

Poznanski SM; Division of Clinical Immunology and Allergy, McMaster University and St Joseph's Healthcare, Hamilton, ON, Canada.
Portillo A; Division of Clinical Immunology and Allergy, McMaster University and St Joseph's Healthcare, Hamilton, ON, Canada.
Mukherjee M; Division of Respirology, McMaster University and St Joseph's Healthcare, Hamilton, ON, Canada.
Bhalla A; Division of Respirology, McMaster University and St Joseph's Healthcare, Hamilton, ON, Canada.
Son K; Division of Respirology, McMaster University and St Joseph's Healthcare, Hamilton, ON, Canada.
Ashkar AA; Division of Clinical Immunology and Allergy, McMaster University and St Joseph's Healthcare, Hamilton, ON, Canada.
Khalidi N; Division of Rheumatology, McMaster University and St Joseph's Healthcare, Hamilton, ON, Canada.
Nair P; Division of Respirology, McMaster University and St Joseph's Healthcare, Hamilton, ON, Canada parames@mcmaster.ca.

Eur Respir J ; 59(4)2022 04.

Article en En | MEDLINE | ID: mdl-34887323

Asunto(s)

Anticuerpos Monoclonales Humanizados; Eosinófilos; Anticuerpos Monoclonales Humanizados/uso terapéutico; Humanos; Células Asesinas Naturales; Recuento de Leucocitos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Eosinófilos / Anticuerpos Monoclonales Humanizados Límite: Humans Idioma: En Revista: Eur Respir J Año: 2022 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google